Skip to main content
. Author manuscript; available in PMC: 2019 Oct 28.
Published in final edited form as: Pediatr Blood Cancer. 2017 Sep 14;65(1):10.1002/pbc.26776. doi: 10.1002/pbc.26776

TABLE 4.

Best Response to Therapy.

Best Response Number of Patients Disease Status at Study Entry
CR 5 NR1= 2, PD= 3
PR 12 PR1= 4, NR1= 2, PR2= 1, NR2= 1, NR3= 1, PD= 3
NR 22 PR1= 5, NR1= 3, PR2= 2, NR2= 2, PD= 10
PD 15 PR1= 4, NR1= 3, PR2= 1, PR3= 1, PD= 6
Not Evaluable 4 PR1= 2, PD= 2

Complete response (CR), Partial response (PR), No response (NR) or stable disease, Progressive disease (PD).